Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Alprolix-rFIXFc-Approved-in-the-EU-for-the-Treatment-of-Haemophilia-B-22353262/?utm_source=whatsapp&utm_medium=social&utm_campaign=share